Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Acquarone

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The Journal of Clinical Investigation|June 17, 2020
Tau is not necessary for amyloid-β-induced synaptic and memory impairmentsDaniela Puzzo, Elentina K Argyrousi, Agnieszka Staniszewski, et al.
Communications Biology|July 14, 2026
Temporal and spatial control of phosphatidylinositides using optogenetics ameliorates behavioral deficits in an Alzheimer's disease mouse modelAna Paula Costa, Erica Acquarone, Artur Lazarian, et al.
Cell Reports|January 13, 2026
Angiopoietin-2 aggravates Alzheimer's disease by promoting blood-brain barrier dysfunction and neuroinflammationEunhyeong Lee, Seoyeon Kim, Claire L Zhu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 13, 2025
PP2A methylesterase, PME-1, and PP2A methyltransferase, LCMT-1, control sensitivity to impairments caused by injury-related oligomeric tauSowmya N Sundaresh, Edward W Vogel, Christopher D Hue, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The Journal of Clinical Investigation|June 17, 2020
Tau is not necessary for amyloid-β-induced synaptic and memory impairmentsDaniela Puzzo, Elentina K Argyrousi, Agnieszka Staniszewski, et al.
Communications Biology|July 14, 2026
Temporal and spatial control of phosphatidylinositides using optogenetics ameliorates behavioral deficits in an Alzheimer's disease mouse modelAna Paula Costa, Erica Acquarone, Artur Lazarian, et al.
Cell Reports|January 13, 2026
Angiopoietin-2 aggravates Alzheimer's disease by promoting blood-brain barrier dysfunction and neuroinflammationEunhyeong Lee, Seoyeon Kim, Claire L Zhu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 13, 2025
PP2A methylesterase, PME-1, and PP2A methyltransferase, LCMT-1, control sensitivity to impairments caused by injury-related oligomeric tauSowmya N Sundaresh, Edward W Vogel, Christopher D Hue, et al.
Pageof 2